Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

40.60 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,834
Open 40.60
Bid (Size) 41.65 (100)
Ask (Size) 42.00 (100)
Prev. Close 40.60
Today's Range 40.60 - 40.60
52wk Range 18.92 - 68.87
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
‘Somebody Knows Something:’ Viking Therapeutics Stock Pops To Nearly 3-Month High As Retail Traders Intensely Speculate On M&A Scenarios
Via Stocktwits
AMD, Oklo, AppLovin Corp, Viking Therapeutics And Novo Nordisk: Why These 5 Stocks Are On Investors' Radars Today
Major U.S. indices closed mixed on Tuesday, with the Dow Jones Industrial Average climbing 1.2% to 47,927.96 and the S&P 500 inching up 0.2% to 6,846.61. 
Via Benzinga
Topics Stocks

Performance

YTD
-1.3%
-1.3%
1 Month
+19.7%
+19.7%
3 Month
+1.9%
+1.9%
6 Month
+46.4%
+46.4%
1 Year
-35.5%
-35.5%

More News

Read More
2 Monster Stocks in the Making
Via The Motley Fool
Novo Nordisk Loses Metsera Bidding War To Pfizer — But Retail Traders Aren’t Losing Faith
Via Stocktwits
Is There a Future for Viking Therapeutics?
Via The Motley Fool
Eli Lilly, Novo Nordisk Or A Dark Horse: Which Obesity-Drug Stock Are Retail Traders Most Bullish On Over Next 5 Years?
Via Stocktwits
Retail Investors Now Expect Viking Therapeutics To Bag A Deal After Novo Nordisk, Pfizer Engage In A Bidding War For Rival Metsera
Via Stocktwits
The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things.
Via Investor's Business Daily
Topics Government
Druckenmiller's Viking Trade Just Hit A Golden Cross — And A Sweet 36% Gain
Via Benzinga
Jim Cramer Says 'Take A Pass' On This Tech Stock, Won't Go Near Oils
Via Benzinga
Here's Why Shares in Viking Therapeutics Shot Higher in October
Via The Motley Fool
Earnings Preview For Viking Therapeutics
Via Benzinga
Billionaire Stanley Druckenmiller Dropped Nvidia and Palantir Stock and Is Piling into 2 Stocks Set to Win in One of the Decade's Hottest Growth Markets.
Via The Motley Fool
Topics Artificial Intelligence
Prediction: The Next Eli Lilly Might Already Be Trading Under $50
Via The Motley Fool
Should You Buy Viking Therapeutics Before Nov. 5?
Via The Motley Fool
3 Promising Growth Stocks That Are Down Around 60% From Their Highs
Via The Motley Fool
Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise
Via Stocktwits
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Viking Therapeutics: High Risk, High Reward Play
Via MarketBeat
Here's Why This Obesity Drug Company's Share Price Soared Today
Via The Motley Fool
Topics Earnings
Why Is Viking Therapeutics Stock Rising Today?
Via Benzinga
Viking Therapeutics Stock Soars After Morgan Stanley’s Price Target Implies A Potential 225% Upside
Via Stocktwits
Topics Artificial Intelligence
Viking Bolts Higher On 'Lightning' Speed Enrollment In Obesity Studies
Via Investor's Business Daily
Viking Therapeutics (NASDAQ:VKTX) Reports Q3 2025 Earnings Miss and 2.8% After-Hours Decline
Via Chartmill
Topics Earnings
Earnings Scheduled For October 22, 2025
Via Benzinga

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 40.60
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 11/11/25 04:00 PM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 4.04B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.